Medicina
Fakultatea
Fudan University
Shangai, ChinaFudan University-ko ikertzaileekin lankidetzan egindako argitalpenak (31)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
The Lancet, Vol. 402, Núm. 10415, pp. 1835-1847
-
Coronary angiography-derived index for assessing microcirculatory resistance in patients with non-obstructed vessels: The FLASH IMR study
American Heart Journal, Vol. 263, pp. 56-63
-
Country-level gender inequality is associated with structural differences in the brains of women and men
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 20
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
-
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 401, Núm. 10391, pp. 1853-1865
2022
-
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
The Lancet Oncology, Vol. 23, Núm. 8, pp. e374-e384
-
Genetic variants associated with longitudinal changes in brain structure across the lifespan
Nature neuroscience, Vol. 25, Núm. 4, pp. 421-432
-
NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805
2021
-
Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
BMC Medical Research Methodology, Vol. 21, Núm. 1
-
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 78, Núm. 8, pp. 840-853
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease
Journal of Nephrology, Vol. 34, Núm. 3, pp. 639-648
-
Resting distal to aortic pressure ratio and fractional flow reserve discordance affects the diagnostic performance of quantitative flow ratio: Results from an individual patient data meta-analysis
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 825-832
-
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696
2020
-
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 10, pp. 1599-1610
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique
Clinical Neurophysiology, Vol. 131, Núm. 6, pp. 1311-1319
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515